JACQUALYN RAUPACH-SPENCER: Open Payments
NPI 1366101354 · GRAFTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 17 payments from 7 companies in 2025. Trend: 2023 $130 · 2024 $84 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| Braintree Laboratories, Inc. | 3 | $167 |
| ABBVIE INC. | 8 | $142 |
| Madrigal Pharmaceuticals | 2 | $52 |
| GENZYME CORPORATION | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| PFIZER INC. | 1 | $15 |
Products named: SUTAB, SKYRIZI, REZDIFFRA, DUPIXENT, ENTYVIO, BREZTRI, LINZESS, RINVOQ.
Industry payments across WV — which companies pay providers there.
